BioSoteria, Inc. Launches First eLearning Course in the eLadder(TM) Safety Series

San Bruno, CA (January 22, 2009) - BioSoteria, Inc. the leading West Coast provider of drug safety and risk management consulting and educational services, launched the initial eLadder™ Safety course in the first-of-its-kind comprehensive, media-rich eLearning training series in drug safety and pharmacovigilance.

Course 1, titled “Drug and Device Development and Regulation,” delivers a comprehensive overview of how medical products, including pharmaceuticals, bio¬logics, and medical devices, are developed and reg¬ulated in the US, Europe, and Japan. This multimedia course features a state-of-the-art integration of text, audio, illustrations, graphics, animations, interactive activities, case studies, review questions, and a final assessment which together engage and challenge the learner to build a comprehensive knowledge base.

Course 1 and all of the courses in the series are developed by a multidisciplinary team of subject-matter experts, instructional designers, animators, graphic designers, programmers, and experts in eLearning delivery and learning management systems.

“We are very proud to be launching a first-of-its kind eLearning program specifically targeting drug safety topics in a course series that will offer drug safety professionals, and those interested in drug safety career track, an opportunity to learn through this innovative, cost effective, interactive program,” said Sally Van Doren, President and Chief Executive Officer of BioSoteria.

Course 1 is specifically designed for to meet the training and educational needs of professionals who are enter¬ing the pharmaceutical or bio¬technology industry in the areas of nonclinical research, clinical research, drug safety and phar¬macovigilance, project manage¬ment, regulatory affairs, medical information or medical affairs, and quality assurance/control.

eLadder™ Safety courses are available for individual and group purchase. Individuals may purchase and complete courses via the Internet through BioSoteria’s website, www.biosoteria.com/eLearning. Course 1 and the entire eLadder Safety program is perfectly designed to meet the needs of healthcare providers (e.g., nurses, pharmacists, and physicians) and industry professionals who are interested in pursuing a career in the very in-demand field of drug safety and pharmacovigilance.

Course 1 and the other courses in the comprehensive eLadder™ Safety curriculum are also available off-the-shelf to corporations who seek to train their safety department employees and contractors. Multi-user licenses and volume discounts are available. To learn more, email contact@biosoteria.com today for a course demo and presentation on the entire eLadder Safety Training Program.

Together, the courses of the core eLadder Safety curriculum form a cohesive training program with one course building on another, thereby offering the learner continuity in their study of drug safety and a comprehensive program built on a solid instructional design architecture. Additional courses in the core eLadderTM Safety curriculum to be released throughout 2009 include the following:

• Clinical Safety Surveillance

• Postmarketing Pharmacovigilance

• Premarket Annual Safety Reports

• Postmarket Periodic Safety Reports

• MedDRA and WHODRUG Coding Conventions

About BioSoteria

BioSoteria delivers high quality, innovative drug safety and risk management consultant services and educational programs to the biopharmaceutical and healthcare community.

Our Mission statement:

BioSoteria is committed to client satisfaction and to providing its clients and strategic partners with comprehensive, knowledgeable, regulatory-compliant, cost-conscious recommendations for drug and medical product safety surveillance consultant services and training. Our commitment to patient safety and public health, as well as the education of medical product safety personnel, are hallmark to our corporate values and mission. We are dedicated to increasing the numbers of qualified medical product safety personnel in academic, governmental, and industry settings through our outreach to health care professionals (e.g., nurses, pharmacists, physicians) in clinical practice and to improving the skills and competencies of existing medical product safety personnel. These are the driving principles by which we conduct business and enter into collaborations with our clients and strategic partners.

For more information about BioSoteria and our services and educational programs, please email contact@biosoteria.com, visit our website at http://biosoteria.com/contact/, or call +1 866-660-5553 (+1 650 616 4151 outside the US).

MORE ON THIS TOPIC